臺北醫學大學泌尿腎臟研究中心

Medicine & Life Sciences

1. Chronic Renal Insufficiency 100%
2. Taiwan 81%
3. Renal Dialysis 67%
4. Kidney 67%
5. Cohort Studies 43%
6. Dialysis 40%
7. Prostatic Neoplasms 39%
8. Chronic Kidney Failure 37%
9. Meta-Analysis 32%
10. Population 30%
11. Autophagy 29%
12. Apoptosis 29%
13. Mortality 29%
14. Neoplasms 24%
15. Confidence Intervals 24%
16. Therapeutics 24%
17. Reactive Oxygen Species 23%
18. Acute Kidney Injury 21%
19. Systematic Reviews 21%
20. Carcinoma 21%
21. Chronic Obstructive Pulmonary Disease 20%
22. Prostate 20%
23. Serum 18%
24. Odds Ratio 18%
25. Indican 17%
26. Down-Regulation 17%
27. Wounds and Injuries 17%
28. Arsenic 17%
29. Proteins 17%
30. Inflammation 16%
31. Heme Oxygenase-1 16%
32. Urinary Bladder Neoplasms 15%
33. Peritoneal Dialysis 15%
34. Endothelin-1 15%
35. Genes 15%
36. Randomized Controlled Trials 15%
37. Urinary Bladder 14%
38. Human Influenza 14%
39. Lung Neoplasms 14%
40. Androgen Receptors 14%
41. Androgens 13%
42. Vaccination 13%
43. Biomarkers 13%
44. Peroxisome Proliferator-Activated Receptors 13%
45. Coronavirus 13%
46. Databases 13%
47. urotensin II 13%
48. Castration 13%
49. Fibrosis 13%
50. Up-Regulation 12%
51. Nanoparticles 12%
52. Recurrence 12%
53. Cardiovascular Diseases 12%
54. Hospitalization 12%
55. Adenocarcinoma of Lung 12%
56. Congenital bilateral aplasia of vas deferens 12%
57. Hypertension 12%
58. Activating Transcription Factor 3 12%
59. ErbB Receptors 11%
60. Human Umbilical Vein Endothelial Cells 11%
61. Triple Negative Breast Neoplasms 11%
62. Neoplasm Metastasis 11%
63. Parathyroid Hormone 11%
64. National Health Programs 11%
65. Metabolic Syndrome 11%
66. Gene Expression 11%
67. Endothelial Cells 11%
68. Heart Failure 11%
69. Growth 11%
70. Propensity Score 10%
71. MicroRNAs 10%
72. In Vitro Techniques 10%
73. Genotype 10%
74. Safety 10%
75. Extracellular Signal-Regulated MAP Kinases 10%
76. Survival 10%
77. Doxorubicin 10%
78. Interleukin-8 10%
79. Incidence 10%
80. Renal Cell Carcinoma 10%
81. Hydroxymethylglutaryl-CoA Reductase Inhibitors 9%
82. Vitamin D 9%
83. Atrial Fibrillation 9%
84. Air Pollution 9%
85. Glomerular Filtration Rate 9%
86. Particulate Matter 9%
87. Cell Proliferation 9%
88. Lipopolysaccharides 9%
89. Herniorrhaphy 9%
90. Case-Control Studies 9%
91. Angiotensin II 9%
92. Blood Pressure 9%
93. Membranous Glomerulonephritis 9%
94. Phosphorylation 9%
95. Cell Line 9%
96. Retrospective Studies 9%
97. Oxidative Stress 9%
98. Bone and Bones 9%
99. Type 2 Diabetes Mellitus 9%
100. Secondary Hyperparathyroidism 9%